Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

1 Feb 2008 10:49

Skyepharma PLC01 February 2008 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: SKYEPHARMA PLC 2. Reason for the notification (please state Yes/No): An acquisition or disposal of voting rights: Yes An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: An event changing the breakdown of voting rights: Other (please specify) : 3. Full name of person(s) subject to the notification obligation: Legal & General Group Plc (L&G) 4. Full name of shareholder(s) Legal & General Assurance (if different from 3.): (Pensions Management) Limited (PMC) 5. Date of the transaction and date on which the threshold is crossed or reached if different): 30 January 2008 6. Date on which issuer notified: 31 January 2008 7. Threshold(s) that is/are crossed or reached: From 3% - 4% (L&G) 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction Number of shares Number of voting Rights ORD 10P 27,597,887 27,597,887GB0008123571 Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible using the ISIN CODE Direct Direct Indirect Direct Indirect ORD 10P 34,254,805 34,254,805 4.20GB0008123571 B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting % of voting financial Period/ Date rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 34,254,805 4.20 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Legal & General Group Plc (Direct and Indirect) (Group) Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) Legal & General Investment Management Limited (Indirect) (LGIM) Legal & General Group Plc (Direct)(L&G) (34,254,805 - 4.20% = LGAS,LGPL & PMC) Legal & General Investment Legal & General Insurance Management (Holdings) Limited Holdings Limited (Direct) (LGIH) (Direct) (LGIMHD) (30,413,206 - 3.73% = PMC) Legal & General Assurance Legal & General Assurance (Pensions Management) Limited (PMC) Society Limited (LGAS & LGPL) (30,413,206 - 3.73% = PMC) Legal & General Pensions Limited (Direct) (LGPL) Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: NOTIFICATION USING THE TOTAL VOTING RIGHTS FIGURE OF 814,988,636 14. Contact name: HELEN LEWIS (LGIM) 15. Contact telephone number: 020 3124 3851 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Apr 20169:33 amRNSAppointment of David Lescuyer as EVP Oral Business
12th Apr 20162:23 pmRNSForm 8.3 - Skyepharma PLC
12th Apr 20162:07 pmRNSForm 8.3 - [Skyepharma plc]
12th Apr 20161:57 pmRNSForm 8.3 - Skyepharma Plc
12th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
12th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
12th Apr 201611:10 amRNSForm 8.5 (EPT/RI) - Skypharma Plc
12th Apr 20169:44 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
11th Apr 20163:15 pmBUSForm 8.3 - Skyepharma Plc
11th Apr 20162:43 pmRNSForm 8.3 - [Skyepharma plc]
11th Apr 20161:00 pmRNSForm 8.3 - Skyepharma PLC
11th Apr 201611:44 amPRNForm 8.3 - Skyepharma Plc
11th Apr 201611:43 amPRNForm 8.3 - Skyepharma Plc
11th Apr 201611:10 amRNSForm 8.5 (EPT/RI) - Skypharma Plc
11th Apr 20169:14 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
11th Apr 20169:12 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
8th Apr 20165:46 pmRNSPublication of Scheme Document
8th Apr 20163:26 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc amendment
8th Apr 20162:00 pmRNSForm 8.3 - Skyepharma PLC
8th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
8th Apr 201611:24 amPRNForm 8.3 - Skyepharma OFFEREE
8th Apr 201611:22 amPRNForm 8.3 - AMENDMENT Skyepharma Plc OFFEREE
8th Apr 201611:01 amRNSForm 8.5 (EPT/RI) - Skypharma Plc
8th Apr 201610:42 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
7th Apr 201612:35 pmRNSForm 8.3 - Skyepharma PLC
7th Apr 201611:58 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
7th Apr 201610:54 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
7th Apr 201610:51 amPRNForm 8.3 OFFEREE - Skyepharma Plc
7th Apr 20169:39 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
7th Apr 20169:30 amRNSAnnual Financial Report
6th Apr 20165:10 pmRNSDirector/PDMR Shareholding
6th Apr 20163:30 pmRNSForm 8 (OPD) Skyepharma PLC
6th Apr 20163:00 pmBUSForm 8.3 - Skyepharma Plc
6th Apr 20162:15 pmRNSForm 8.3 - Skyepharma PLC
6th Apr 201612:07 pmRNSForm 8 (DD) - Skyepharma PLC
6th Apr 201612:05 pmRNSForm 8 (DD) - Skyepharma PLC
6th Apr 201610:14 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
6th Apr 201610:08 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
6th Apr 20169:35 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
6th Apr 20169:25 amRNSForm 8.5 (EPT/RI) - Skypharma Plc
5th Apr 20163:05 pmBUSForm 8.3 - Skyepharma Plc
5th Apr 20163:00 pmRNSForm 8.3 - Skypepharma PLC
5th Apr 201611:12 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
5th Apr 20169:32 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
5th Apr 20169:30 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
4th Apr 20163:00 pmRNSForm 8.3 - Skyepharma PLC
4th Apr 20162:59 pmRNSForm 8.3 - Skyepharma Plc
4th Apr 20162:17 pmRNSForm 8.3 - Skyepharma Plc
4th Apr 201610:29 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
4th Apr 201610:29 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.